EUVIMEDEUVIMED entdecken
Crossref

ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice

Nan Hu iD, Meng Sun, Nan Lv, Yangyang Gao, Xiaohong Fu, Dayi Xing, Xiang Guo, Shaodong Zhai iD, Ruiping Zhang iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.3c16735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Nan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 99 Longcheng Street…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Myocardial Infarction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Shanxi Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorMyocardial InfarctionMiceAnimalsReactive Oxygen SpeciesNiclosamideMyocytes, CardiacOxidative StressAdenosine TriphosphateMalonatesApoptosis

Stichwörter der Autor:innen

apoptosiscardioprotectionmyocardial infarctionoxidative stressresponsive drug release

Substanzen

Reactive Oxygen SpeciesSTAT3 Transcription FactorNiclosamideAdenosine TriphosphateMalonates

Autor:innen und Institutionen

  • Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 99 Longcheng Street, Taiyuan 030032, China.
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan 430030, China.
  • Cardiology Department, First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030032, China.
  • Department of Biochemistry and Molecular Biology, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030032, China.
  • The First Clinical Medical College, Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030001, China.
  • The Radiology Department of Shanxi Provincial People's Hospital, The Fifth Hospital of Shanxi Medical University, Taiyuan 030001, China.

ORCID-Profile: Nan Hu, Shaodong Zhai, Ruiping Zhang

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Shanxi Province
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Bethune Hospital of Shanxi Medical University
  • Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province

Zitieren

APA

Hu, N., Sun, M., Lv, N., Gao, Y., Fu, X., Xing, D., Guo, X., Zhai, S., & Zhang, R. (2024). ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c16735

Vancouver

Hu N, Sun M, Lv N, Gao Y, Fu X, Xing D, et al. ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.3c16735

BibTeX
@article{Hu2024,
  author = {Hu, Nan and Sun, Meng and Lv, Nan and Gao, Yangyang and Fu, Xiaohong and Xing, Dayi and Guo, Xiang and Zhai, Shaodong and Zhang, Ruiping},
  title = {ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.3c16735}
}
Kostenlos starten →